Docosahexaenoic acid acts as QT-shortening agent with genotype-specific beneficial effects in transgenic LQT1, LQT2, LQT5 and LQT2-5 rabbit models
                              
 
                                  Event:
                                  
                                    ESC Congress 2018
                                  
 
                                  Topic:
                                  
                                    Drug Treatment of Ventricular Arrhythmias
                                  
 
                                  Session:
                                  
                                    Best Posters in ventricular arrythmias and SCD